Exhibitors Search
Dongnam Institute of Radiological & Medical Sciences

Booth no.
B51
Exhibition | NextRegenX |
---|---|
Country | Korea, South |
Address | 40 Jwadong-gil, Jangan-eup, Gijang-gun, Busan, Republic of Korea |
Tel (Rep.) | 051-720-5873 |
Website | http://www.dirams.re.kr |
Company Introduction
DIRAMS, a hospital under the Ministry of Science and ICT, provides specialized cancer care by integrating advanced biomedical research into clinical practice. It prioritizes public health, using cutting-edge technologies, offering integrated care, and implementing government health policies.
The Radiation Emergency Medical Center prepares for radiation accidents, operating the Radiation Impact Clinic for exposure assessments and medical exams, while educating residents near nuclear plants.
In December 2023, DIRAMS opened the Radiomedical Commercialization Center to advance cancer treatments through the fusion of radiology and biology, serving as a platform to accelerate research commercialization and train physician-scientists.
With 60 years of experience from the Korea Institute of Radiological Medical Sciences, DIRAMS aims to lead cancer diagnostics and treatments, becoming a key institution in the Southeast region's radiation medicine industry.
The Radiation Emergency Medical Center prepares for radiation accidents, operating the Radiation Impact Clinic for exposure assessments and medical exams, while educating residents near nuclear plants.
In December 2023, DIRAMS opened the Radiomedical Commercialization Center to advance cancer treatments through the fusion of radiology and biology, serving as a platform to accelerate research commercialization and train physician-scientists.
With 60 years of experience from the Korea Institute of Radiological Medical Sciences, DIRAMS aims to lead cancer diagnostics and treatments, becoming a key institution in the Southeast region's radiation medicine industry.
Promotional video
Exhibit Item
.
Exhibit Item Images
-
Product Name : Method for Producing Dedifferentiated Fat Cells Derived from Adipose Tissue Using CentrifugationThis technology is a method for producing dedifferentiated stem cells from adipose-derived cells using centrifugal force. Compared to conventional ceiling culture methods, it significantly shortens the production period and requires no cultivation, making it highly useful in the field of adipose-derived stem cell therapeutics
-
Product Name : Multi-Artificial Neural Network-Based Human Radiation Dose Assessment ProgramChromosome Reading System for Radiation Exposure Diagnosis. By utilizing deep learning-based object recognition, it enhances the accuracy of biological dose assessment and reduces the reading time
-
Product Name : Development of Low-Toxicity Anti-Cancer Metastasis Therapeutics Based on Exosome ModulationDevelopment of novel drug candidates (AR-20001, AR-22003) as activators of antioxidant response enzymes, designed to inhibit cancer metastasis by suppressing exosome secretion from cancer cells, selectively blocking cell motility and invasiveness without inducing apoptosis
-
Product Name : A composition comprising an anmidenol derivative as an active ingredient for enhancing radiosensitivity and for the prevention or treatment of tumorsAn anmidenol derivative derived from marine bacteria exhibits cytotoxic effects on tumor cells and can be utilized as a radiosensitizer in combination with radiation therapy for cancer treatment
-
Product Name : A high-efficiency method for the large-scale expansion of natural killer (NK) cells isolated from whole bloodThe use of autologous cells eliminates potential risks associated with tumor cells, enabling the efficient large-scale expansion of natural killer (NK) cells to high purity (>98%) and high activity, with over 10,000-fold amplification. The methods for cell expansion and activation are reproducible and stable, thereby making them suitable for clinic
Exhibit Description
.
Co-Exhibitor or
Partner’s Information
Company Name | Country |
---|---|